Current practice converges around three tiers: The split-dose protocol (250 mcg morning, 250 mcg 3+ hours post-meal in the evening) creates two daily windows of lipolytic stimulation
There is currently no significant body of scientific evidence from human clinical trials to suggest that it directly stimulates lipolysis (the breakdown of fat) or dramatically boosts metabolic rate in the way that compounds like caffeine, ephedrine, or even proven medications do
This is particularly relevant when patients: Skip meals Eat smaller portions Avoid protein-rich foods due to nausea Reduce dietary variety The medication itself does not remove nutrients
Sepsis is a severe condition characterized by systemic inflammation, metabolic disturbances, oxidative stress, endothelial dysfunction, and ultimately, poor tissue perfusion
*Correspondence: Giuseppina Piazzolla, [email protected]